[1] 裴小锐,顾梅,张振蔚.利伐沙班与华法林对老年非瓣膜病心房颤动合并肾功能不全的疗效[J].西北药学杂志,2024,39(4):116-120.
[2] 尤佳,朱业,顾翔.老年心房颤动患者华法林抗凝治疗的临床管理病例分析二例[J].中华老年心脑血管病杂志,2023,25(7):764-765.
[3] 陈玉新,成家军,李晶.不同华法林抗凝对老年稳定性冠状动脉粥样硬化性心脏病并发非瓣膜性心房颤动患者疗效观察[J].血栓与止血学,2022,28(3):395-396.
[4] Harris DE, Thayer D, Wang T, et al.An observational study of international normalized ratio control according to NICE criteria in patients with non-valvular atrial fibrillation: the SAIL Warfarin Out of Range Descriptors Study (SWORDS)[J].Eur Heart J Cardiovasc Pharmacother,2021,7(1):40-49.
[5] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.心房颤动基层诊疗指南(2019年)[J].中华全科医师杂志,2020,19(6):465-473.
[6] 张塬坤,赵友民,郝冬琴,等.华法林不同抗凝强度对老年冠心病合并非瓣膜性心房颤动病人凝血-纤溶系统、肝肾功能和出血风险的影响[J].中西医结合心脑血管病杂志,2024,22(2):337-340.
[7] Asiimwe IG, Zhang EJ, Osanlou R, et al.Warfarin dosing algorithms: A systematic review[J].Br J Clin Pharmacol,2021,87(4):1717-1729.
[8] Zhang Y, Xie C, Xue L, et al.A Post-Hoc Interpretable Ensemble Model to Feature Effect Analysis in Warfarin Dose Prediction for Chinese Patients[J].IEEE J Biomed Health Inform,2022,26(2):840-851.
[9] 范彩霞,李娇,魏延津,等.心房颤动患者华法林抗凝治疗初期发生抗凝过度的影响因素研究[J].中国全科医学,2024,27(3):308-314.
[10] Karakasis P, Ktenopoulos N, Pamporis K, et al.Efficacy and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients (BMI ≥ 30 kg/m2) with Atrial Fibrillation or Venous Thromboembolism: An Updated Systematic Review and Meta-Analysis[J].J Clin Med,2024,13(13):3784-3798.
[11] Patel SM, Braunwald E, Steffel J, et al.Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation[J].Circulation,2024,149(12):932-943.
[12] Cohen JL, Thompson E, Sinvani L, et al.Assessment of warfarin algorithms for hospitalized adults: searching for a safe dosing strategy[J].J Thromb Thrombolysis,2019,48(4):570-579.
[13] 黄晓丽,姚笑睿,朱天翔,等.1913例门诊患者华法林处方应用分析[J].海峡药学,2020,32(8):94-96.
[14] 李峥嵘,张宗林,欧知宏,等.与华法林联用致住院患者INR异常升高药物分析[J].药物不良反应杂志,2017,19(4):260-266.
[15] Ren Y,Yang C,Chen H, et al.Pharmacogenetic-Guided Algorithm to Improve Daily Dose of Warfarin in Elder Han-Chinese Population[J].Front Pharmacol,2020,11(1):1-9. |
